NasdaqGM - Nasdaq Real Time Price USD
Immuneering Corporation (IMRX)
1.1696
-0.0204
(-1.71%)
As of 12:30:30 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BERMAN ANN E Director | Purchase | Mar 18, 2024 | 67,465 |
BOOKMAN MICHAEL Officer | Stock Award(Grant) | Mar 15, 2024 | 3,850 |
BRAKEWOOD HAROLD EUGENE Officer | Purchase | Mar 22, 2024 | 3,900 |
CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Sale | Apr 1, 2024 | -- |
FEINBERG PETER Director | Purchase | Mar 22, 2024 | 1,096,060 |
HALL BRETT MATTHEW Officer | Purchase | Mar 20, 2024 | 345,896 |
MORALES MALLORY Officer | Stock Award(Grant) | Sep 13, 2024 | 12,736 |
NEUFELD LEAH R Officer | Purchase | Mar 20, 2024 | 10,029 |
SCHALL THOMAS J Director | Purchase | Mar 22, 2024 | 2,900 |
ZESKIND BENJAMIN J Chief Executive Officer | Purchase | Mar 19, 2024 | 3,176,780 |
Related Tickers
JSPR Jasper Therapeutics, Inc.
4.3500
-1.79%
MRSN Mersana Therapeutics, Inc.
0.3133
-6.48%
ABOS Acumen Pharmaceuticals, Inc.
1.0035
+0.35%
DSGN Design Therapeutics, Inc.
3.5200
0.00%
XLO Xilio Therapeutics, Inc.
0.7100
-1.39%
TVRD Tvardi Therapeutics, Inc.
26.60
+2.11%
GBIO Generation Bio Co.
0.3659
+1.70%
INAB IN8bio, Inc.
0.1603
-4.53%
INZY Inozyme Pharma, Inc.
1.2050
-2.82%
ERAS Erasca, Inc.
1.3750
-1.08%